-
Covid-19 vaccine: ICMR to examine effectiveness of Covishield and Covaxin
The cumulative vaccine doses administered in the country has crossed 20 crore so far
-
Covishield stock for 45+ age group left for 12 days: Atishi
On May 25, of the 43,824 doses administered, over 33,000 were given to those getting their first shots and about 10,000 for those receiving their seco
-
Covid-19 positivity rate down to 9.54%: Union health ministry
India's daily recoveries continue to outnumber the daily new cases for the 12th consecutive day
-
Karnataka receives 3 lakh Covishield vaccines from Centre
Karnataka has received 3 lakh doses of Covishield today under the Central quota
-
Covid-19 vaccine: Covaxin, Covishield production to be ramped up to a billion doses
Bharat Biotech and Serum Institute of India have announced plans to ramp up production
-
Two doses of Oxford-AstraZeneca vaccine are 85-90% effective, real-world study finds
New analysis for the first time estimates that two doses of the Oxford-AstraZeneca vaccine provide around 85 to 90% protection against covid-19.
-
Government panel to study feasibility of administering doses of different vaccines
Currently, doctors recommend both the doses of the Covid-19 vaccine should be from the same manufacturer
-
More pharma firms should be allowed to make vaccine: Nitin Gadkari
There are two vaccine makers in the country currently -- Bharat Biotech and Serum Institute of India -- which are manufacturing Covaxin and Covishield
-
Miniscule bleeding, clotting events post Covishield inoculation in India
The Union Health Ministry said in a statement on Monday that over 23,000 adverse events have been reported since the vaccination drive involving Covis
-
Covid-19: A look at states where cases have dipped and vaccination drive has gained momentum
States which have been affected the most in the second wave of Covid-19 are now witnessing a dip in new cases
